These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 1352058)

  • 21. Diazepam withdrawal: effects of diazepam and gepirone on acoustic startle-induced 22 kHz ultrasonic vocalizations.
    Vivian JA; Farrell WJ; Sapperstein SB; Miczek KA
    Psychopharmacology (Berl); 1994 Feb; 114(1):101-8. PubMed ID: 7846191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.
    Chopin P; Assié MB; Briley M
    Psychopharmacology (Berl); 1993; 110(1-2):19-26. PubMed ID: 7870883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
    Barnes NM; Cheng CH; Costall B; Ge J; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1992 Jul; 218(1):91-100. PubMed ID: 1356807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice.
    Matsumoto K; Mizowaki M; Thongpraditchote S; Murakami Y; Watanabe H
    Pharmacol Biochem Behav; 1997 Mar; 56(3):417-22. PubMed ID: 9077577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABAA/benzodiazepine neurotransmission.
    Chioca LR; Ferro MM; Baretta IP; Oliveira SM; Silva CR; Ferreira J; Losso EM; Andreatini R
    J Ethnopharmacol; 2013 May; 147(2):412-8. PubMed ID: 23524167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the involvement of 5-HT1A receptors in the anticonflict effect of ipsapirone in rats.
    Chojnacka-Wójcik E; Przegaliński E
    Neuropharmacology; 1991 Jul; 30(7):703-9. PubMed ID: 1681448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine.
    Paine TA; Jackman SL; Olmstead MC
    Behav Pharmacol; 2002 Nov; 13(7):511-23. PubMed ID: 12409990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice.
    Kuribara H; Stavinoha WB; Maruyama Y
    J Pharm Pharmacol; 1998 Jul; 50(7):819-26. PubMed ID: 9720634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral effects of acute and chronic oral administration of barakol in rats.
    Deachapunya C; Thongsaard W
    J Med Assoc Thai; 2009 Jun; 92 Suppl 3():S29-37. PubMed ID: 19702066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.
    de Mello Cruz AP; Pinheiro G; Alves SH; Ferreira G; Mendes M; Faria L; Macedo CE; Motta V; Landeira-Fernandez J
    Psychopharmacology (Berl); 2005 Nov; 182(3):345-54. PubMed ID: 16133141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone.
    Moser PC
    Psychopharmacology (Berl); 1989; 99(1):48-53. PubMed ID: 2528779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute effect of Copaifera reticulata Ducke copaiba oil in rats tested in the elevated plus-maze: an ethological analysis.
    Curio M; Jacone H; Perrut J; Pinto AC; Filho VF; Silva RC
    J Pharm Pharmacol; 2009 Aug; 61(8):1105-10. PubMed ID: 19703355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
    Eroğlu L; Güven O
    Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action.
    Fernández-Guasti A; Hong E; López-Rubalcava C
    Psychopharmacology (Berl); 1992; 107(1):61-8. PubMed ID: 1350351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withdrawal syndrome following subchronic treatment with anxiolytic agents.
    Barry JM; Costall B; Kelly ME; Naylor RJ
    Pharmacol Biochem Behav; 1987 Jun; 27(2):239-45. PubMed ID: 2888134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The elevated T-maze as an experimental model of anxiety.
    Graeff FG; Netto CF; Zangrossi H
    Neurosci Biobehav Rev; 1998; 23(2):237-46. PubMed ID: 9884116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.
    Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1993 Nov; 110(3):1079-84. PubMed ID: 7507776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze.
    Mansouri MT; Soltani M; Naghizadeh B; Farbood Y; Mashak A; Sarkaki A
    Pharmacol Biochem Behav; 2014 Feb; 117():40-6. PubMed ID: 24345572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.